{"id":215,"date":"2017-10-27T11:01:30","date_gmt":"2017-10-27T11:01:30","guid":{"rendered":"https:\/\/www-menarah-org.kentuniresestg.wpengine.com\/?p=215"},"modified":"2024-01-08T09:56:17","modified_gmt":"2024-01-08T09:56:17","slug":"dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model","status":"publish","type":"post","link":"https:\/\/menarah.org\/ar\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/","title":{"rendered":"\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u062d\u062a\u0645\u0644 \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c \u0627\u0644\u062e\u0644\u0648\u064a"},"content":{"rendered":"

\u064a\u0634\u0645\u0644 \u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u0646 \u0627\u0644\u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a \u0627\u0644\u0646\u0627\u062c\u0645\u0629 \u0639\u0646 \u062a\u062c\u0645\u0639\u0627\u062a \u063a\u064a\u0631 \u0637\u0628\u064a\u0639\u064a\u0629 \u0645\u0646 \u0628\u0631\u0648\u062a\u064a\u0646 \u062a\u0627\u0648. \u0641\u064a \u0647\u0630\u0647 \u0627\u0644\u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a\u060c \u064a\u0645\u064a\u0644 \u0628\u0631\u0648\u062a\u064a\u0646 \u062a\u0627\u0648 \u0627\u0644\u0645\u0641\u0633\u0641\u0631 \u0625\u0644\u0649 \u0627\u0644\u062a\u0631\u0627\u0643\u0645 \u062f\u0627\u062e\u0644 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0639\u0635\u0628\u064a\u0629 (\u0633\u0648\u0645\u0627) \u0628\u062f\u0644\u0627\u064b \u0645\u0646 \u0627\u0644\u062a\u0648\u0632\u064a\u0639 \u0627\u0644\u0645\u062d\u0648\u0631\u064a \u0627\u0644\u0637\u0628\u064a\u0639\u064a \u0644\u062a\u0627\u0648. \u062a\u062a\u0645\u062b\u0644 \u0627\u0644\u0625\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a\u0629 \u0627\u0644\u0639\u0644\u0627\u062c\u064a\u0629 \u0627\u0644\u0645\u0642\u062a\u0631\u062d\u0629 \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648 \u0641\u064a \u062a\u062d\u0641\u064a\u0632 \u0627\u0644\u0627\u0644\u062a\u0647\u0627\u0645 \u0627\u0644\u0630\u0627\u062a\u064a \u0644\u0632\u064a\u0627\u062f\u0629 \u0627\u0644\u0642\u062f\u0631\u0629 \u0639\u0644\u0649 \u0627\u0644\u062a\u062e\u0644\u0635 \u0645\u0646 \u062a\u062c\u0645\u0639\u0627\u062a \u062a\u0627\u0648 \u063a\u064a\u0631 \u0627\u0644\u0645\u0631\u063a\u0648\u0628 \u0641\u064a\u0647\u0627. \u0623\u062d\u062f \u0623\u062f\u0648\u0627\u062a \u0627\u0644\u062a\u062d\u0643\u0645 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0641\u064a \u0627\u0644\u0627\u0644\u062a\u0647\u0627\u0645 \u0627\u0644\u0630\u0627\u062a\u064a \u0647\u0648 mTOR. \u064a\u0624\u062f\u064a \u062d\u0638\u0631 mTOR \u0625\u0644\u0649 \u062a\u062d\u0641\u064a\u0632 \u0627\u0644\u0627\u0644\u062a\u0647\u0627\u0645 \u0627\u0644\u0630\u0627\u062a\u064a. \u0641\u064a \u0627\u0644\u0622\u0648\u0646\u0629 \u0627\u0644\u0623\u062e\u064a\u0631\u0629\u060c \u0623\u0638\u0647\u0631 \u0643\u0634\u0641 \u0627\u0644\u062a\u0631\u0643\u064a\u0628 \u0627\u0644\u062c\u0632\u064a\u0626\u064a \u0644\u0640 mTOR \u0623\u0646\u0647 \u064a\u062a\u0643\u0648\u0646 \u0645\u0646 \u0648\u062d\u062f\u062a\u064a\u0646 \u0641\u0631\u0639\u064a\u062a\u064a\u0646: mTORC1\/C2. \u0644\u0630\u0627\u060c \u064a\u0628\u062f\u0648 \u062d\u0638\u0631 \u0643\u0644\u062a\u0627 \u0627\u0644\u0648\u062d\u062f\u062a\u064a\u0646 \u0627\u0644\u0641\u0631\u0639\u064a\u062a\u064a\u0646 \u0645\u0646 mTOR \u0623\u0643\u062b\u0631 \u062c\u0627\u0630\u0628\u064a\u0629 \u0644\u0623\u0646\u0647 \u0633\u064a\u0633\u062a\u0643\u0634\u0641 \u062c\u0645\u064a\u0639 \u0642\u062f\u0631\u0627\u062a \u062c\u0632\u064a\u0621 mTOR. \u0641\u064a \u0647\u0630\u0647 \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0642\u0645\u0646\u0627 \u0628\u0627\u0644\u0625\u0628\u0644\u0627\u063a \u0639\u0646 \u0627\u0633\u062a\u062e\u062f\u0627\u0645 pp242 \u0648\u0647\u0648 \u0645\u0627\u0646\u0639 \u0645\u0632\u062f\u0648\u062c mTORC1\/C2 \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c \u0627\u0644\u062e\u0644\u0648\u064a \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u062e\u0637 \u062e\u0644\u0627\u064a\u0627 LUHMES. \u0623\u062f\u062a \u0625\u0636\u0627\u0641\u0629 \u0627\u0644\u0641\u064a\u0646\u0627\u0632\u0627\u0643\u064a\u0646 \u0625\u0644\u0649 \u062e\u0644\u0627\u064a\u0627 LUHMES \u0625\u0644\u0649 \u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a \u0641\u064a \u0634\u0643\u0644 \u0632\u064a\u0627\u062f\u0629 \u0641\u064a \u0645\u062c\u0627\u0645\u064a\u0639 \u0627\u0644\u0641\u0648\u0633\u0641\u0648 \u062a\u0627\u0648. \u0639\u0644\u0627\u0648\u0629 \u0639\u0644\u0649 \u0630\u0644\u0643\u060c \u0623\u0638\u0647\u0631\u062a \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0645\u0639\u0627\u0644\u062c\u0629 \u0628\u0627\u0644\u0641\u064a\u0646\u0627\u0632\u0627\u0643\u0648\u064a\u0646 \u0625\u0639\u0627\u062f\u0629 \u0627\u0644\u062a\u0648\u0632\u064a\u0639 \u0627\u0644\u062c\u0633\u062f\u064a \u0627\u0644\u0645\u0645\u064a\u0632 \u0644\u0628\u0631\u0648\u062a\u064a\u0646 \u062a\u0627\u0648. \u0623\u062f\u0649 \u0627\u0633\u062a\u062e\u062f\u0627\u0645 PP242 \u0641\u064a \u0646\u0645\u0648\u0630\u062c \u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a \u0627\u0644\u062d\u0627\u0644\u064a \u0625\u0644\u0649 \u0639\u0643\u0633 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0645\u0631\u0636\u064a\u0629 \u0628\u0634\u0643\u0644 \u0645\u0644\u062d\u0648\u0638 \u062f\u0648\u0646 \u0633\u0645\u064a\u0629 \u062e\u0644\u0648\u064a\u0629 \u0645\u0644\u062d\u0648\u0638\u0629 \u0644\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0627\u0644\u0628\u0627\u0644\u063a\u0629 1000 \u0646\u0627\u0646\u0648\u0645\u062a\u0631. \u062a\u0642\u062a\u0631\u062d \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u062d\u0627\u0644\u064a\u0629 \u0625\u0645\u0643\u0627\u0646\u064a\u0629 \u0627\u0633\u062a\u062e\u062f\u0627\u0645 pp242 \u0643\u062d\u0627\u062c\u0632 \u0645\u0632\u062f\u0648\u062c \u0644\u0640 mTOR \u0644\u0639\u0644\u0627\u062c \u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648\u0648\u0628\u0627\u062b\u064a.<\/p>\n\n\n\n

\u0633\u0644\u0627\u0645\u0629<\/strong> \u0645\u060c \u0627\u0644\u062d\u0633\u064a\u0646\u064a \u0645\u060c \u0645\u062c\u062f\u064a \u0623\u060c \u0639\u0645\u0631\u0627\u0646 \u0623\u060c \u0627\u0644\u0633\u064a\u062f \u0623\u060c \u0639\u0634\u0631\u064a \u0623\u060c \u0645\u062d\u0645\u062f \u0648. 2017. \u0645\u0627\u0646\u0639 mTORC1 \/ mTORC2 \u0627\u0644\u0645\u0632\u062f\u0648\u062c \u0643\u0639\u0644\u0627\u062c \u0645\u062d\u062a\u0645\u0644 \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648 \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c \u0627\u0644\u062e\u0644\u0648\u064a<\/a>. \u0645\u064a\u062a\u0627\u0628 \u0628\u0631\u064a\u0646 \u062f\u064a\u0633 33(2)\u060c 583-587.<\/p>","protected":false},"excerpt":{"rendered":"

Tauopathy comprises a group of disorders caused by abnormal aggregates of tau protein. In these disorders phosphorylated tau protein tends to accumulate inside neuronal cells (soma) instead of the normal axonal distribution of tau. A suggested therapeutic strategy for tauopathy is to induce autophagy to increase the ability to get rid of the unwanted tau […]<\/p>\n","protected":false},"author":13,"featured_media":351,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,17],"tags":[23,61,95],"class_list":{"0":"post-215","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-international_learning","8":"category-publications","9":"tag-23","10":"tag-health","11":"tag-research"},"yoast_head":"\nPossible therapy for tauopathy in cellular model - Menarah<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/menarah.org\/ar\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Possible therapy for tauopathy in cellular model - Menarah\" \/>\n<meta property=\"og:description\" content=\"Tauopathy comprises a group of disorders caused by abnormal aggregates of tau protein. In these disorders phosphorylated tau protein tends to accumulate inside neuronal cells (soma) instead of the normal axonal distribution of tau. A suggested therapeutic strategy for tauopathy is to induce autophagy to increase the ability to get rid of the unwanted tau […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/menarah.org\/ar\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/\" \/>\n<meta property=\"og:site_name\" content=\"Menarah\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-27T11:01:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-08T09:56:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1632\" \/>\n\t<meta property=\"og:image:height\" content=\"442\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dr. Mohamed Salama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mohamed Salama\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/\"},\"author\":{\"name\":\"Dr. Mohamed Salama\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\"},\"headline\":\"Possible therapy for tauopathy in cellular model\",\"datePublished\":\"2017-10-27T11:01:30+00:00\",\"dateModified\":\"2024-01-08T09:56:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/\"},\"wordCount\":233,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.27.01.png\",\"keywords\":[\"2017\",\"Health\",\"Research\"],\"articleSection\":[\"Learning from the International Experience\",\"Publications\"],\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/\",\"url\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/\",\"name\":\"Possible therapy for tauopathy in cellular model - Menarah\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.27.01.png\",\"datePublished\":\"2017-10-27T11:01:30+00:00\",\"dateModified\":\"2024-01-08T09:56:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#primaryimage\",\"url\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.27.01.png\",\"contentUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-26-at-14.27.01.png\",\"width\":1632,\"height\":442},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/menarah.org\\\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/menarah.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Possible therapy for tauopathy in cellular model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#website\",\"url\":\"https:\\\/\\\/menarah.org\\\/\",\"name\":\"Menarah\",\"description\":\"Middle East & North Africa Research on Ageing Healthy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/menarah.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/menarah.org\\\/#\\\/schema\\\/person\\\/31d8b4616fa7455ebb0b07916a647a77\",\"name\":\"Dr. Mohamed Salama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"url\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/menarah.org\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/M_Salama_photo-1.jpg\",\"caption\":\"Dr. Mohamed Salama\"},\"description\":\"Institute of Global Health and Human Ecology,\u00a0American University in Cairo, Egypt Dr Mohamed Salama established the first Translational Neuroscience Unit in Egypt. Mohamed\u2019s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders (ENND). Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational\\\/bridging awardee in 2016. He was awarded by Parkinson\u2019s and Movement Disorders Foundation (PMDF) for his continuing research in the field of neurodegeneration. Recently, Mohamed and his colleagues succeeded to draft the first Reference Egyptian Genome\u00a0and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).\u00a0Currently, Mohamed is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC).\",\"url\":\"https:\\\/\\\/menarah.org\\\/ar\\\/author\\\/mohamedsalama\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u062d\u062a\u0645\u0644 \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648 \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c \u0627\u0644\u062e\u0644\u0648\u064a - \u0645\u0646\u0627\u0631\u0629","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/menarah.org\/ar\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/","og_locale":"ar_AR","og_type":"article","og_title":"Possible therapy for tauopathy in cellular model - Menarah","og_description":"Tauopathy comprises a group of disorders caused by abnormal aggregates of tau protein. In these disorders phosphorylated tau protein tends to accumulate inside neuronal cells (soma) instead of the normal axonal distribution of tau. A suggested therapeutic strategy for tauopathy is to induce autophagy to increase the ability to get rid of the unwanted tau […]","og_url":"https:\/\/menarah.org\/ar\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/","og_site_name":"Menarah","article_published_time":"2017-10-27T11:01:30+00:00","article_modified_time":"2024-01-08T09:56:17+00:00","og_image":[{"width":1632,"height":442,"url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png","type":"image\/png"}],"author":"Dr. Mohamed Salama","twitter_card":"summary_large_image","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Dr. Mohamed Salama","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#article","isPartOf":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/"},"author":{"name":"Dr. Mohamed Salama","@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77"},"headline":"Possible therapy for tauopathy in cellular model","datePublished":"2017-10-27T11:01:30+00:00","dateModified":"2024-01-08T09:56:17+00:00","mainEntityOfPage":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/"},"wordCount":233,"commentCount":0,"image":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#primaryimage"},"thumbnailUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png","keywords":["2017","Health","Research"],"articleSection":["Learning from the International Experience","Publications"],"inLanguage":"ar","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/","url":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/","name":"\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u062d\u062a\u0645\u0644 \u0644\u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u062a\u0627\u0648 \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c \u0627\u0644\u062e\u0644\u0648\u064a - \u0645\u0646\u0627\u0631\u0629","isPartOf":{"@id":"https:\/\/menarah.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#primaryimage"},"image":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#primaryimage"},"thumbnailUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png","datePublished":"2017-10-27T11:01:30+00:00","dateModified":"2024-01-08T09:56:17+00:00","author":{"@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77"},"breadcrumb":{"@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#primaryimage","url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png","contentUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01.png","width":1632,"height":442},{"@type":"BreadcrumbList","@id":"https:\/\/menarah.org\/dual-mtorc1-mtorc2-blocker-as-a-possible-therapy-for-tauopathy-in-cellular-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/menarah.org\/"},{"@type":"ListItem","position":2,"name":"Possible therapy for tauopathy in cellular model"}]},{"@type":"WebSite","@id":"https:\/\/menarah.org\/#website","url":"https:\/\/menarah.org\/","name":"\u0645\u0646\u0627\u0631\u0629","description":"\u0623\u0628\u062d\u0627\u062b \u0627\u0644\u0634\u0631\u0642 \u0627\u0644\u0623\u0648\u0633\u0637 \u0648\u0634\u0645\u0627\u0644 \u0623\u0641\u0631\u064a\u0642\u064a\u0627 \u062d\u0648\u0644 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0635\u062d\u064a\u0629","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/menarah.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Person","@id":"https:\/\/menarah.org\/#\/schema\/person\/31d8b4616fa7455ebb0b07916a647a77","name":"\u062f\u0643\u062a\u0648\u0631 \u0645\u062d\u0645\u062f \u0633\u0644\u0627\u0645\u0629","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","url":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","contentUrl":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/05\/M_Salama_photo-1.jpg","caption":"Dr. Mohamed Salama"},"description":"Institute of Global Health and Human Ecology,\u00a0American University in Cairo, Egypt Dr Mohamed Salama established the first Translational Neuroscience Unit in Egypt. Mohamed\u2019s collaborative research led to establishing the Egyptian Network for Neurodegenerative Disorders (ENND). Mohamed was selected as a SOT Global Senior Scholar in 2013 and Translational\/bridging awardee in 2016. He was awarded by Parkinson\u2019s and Movement Disorders Foundation (PMDF) for his continuing research in the field of neurodegeneration. Recently, Mohamed and his colleagues succeeded to draft the first Reference Egyptian Genome\u00a0and collaborating with other colleagues to start a national cohort (A Longitudinal Study of Egyptian Health Aging [AL-SEHA]).\u00a0Currently, Mohamed is Atlantic senior fellow for Equity in brain health at the Global Brain Health Institute (GBHI) and Associate professor at the Institute of Global Health and Human Ecology at the American University in Cairo (AUC).","url":"https:\/\/menarah.org\/ar\/author\/mohamedsalama\/"}]}},"featured_image_src":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01-600x400.png","featured_image_src_square":"https:\/\/menarah.org\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-26-at-14.27.01-600x442.png","author_info":{"display_name":"Dr. Mohamed Salama","author_link":"https:\/\/menarah.org\/ar\/author\/mohamedsalama\/"},"_links":{"self":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/comments?post=215"}],"version-history":[{"count":1,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/215\/revisions"}],"predecessor-version":[{"id":1533,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/posts\/215\/revisions\/1533"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/media\/351"}],"wp:attachment":[{"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/media?parent=215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/categories?post=215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/menarah.org\/ar\/wp-json\/wp\/v2\/tags?post=215"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}